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ABSTRACT 23 
The Burkholderia cepacia complex (Bcc) consists of 20 closely related gram-negative 24 
bacterial species that are significant pathogens for persons with cystic fibrosis (CF). Some Bcc 25 
strains are highly transmissible and resistant to multiple antibiotics, making infection difficult to 26 
treat.  A tailocin (phage-tail-like bacteriocin), designated BceTMilo, with broad host range 27 
against members of the Bcc was identified in Burkholderia cenocepacia strain BC0425. Sixty-28 
eight percent of Bcc representing 10 species and 90% of non-Bcc Burkholderia strains tested 29 
were sensitive to BceTMilo. BceTMilo also showed killing activity against Pseudomonas 30 
aeruginosa PAO1 and derivatives. Liquid chromatography-mass spectrometry analysis of the 31 
major BceTMilo proteins was used to identify a 23 kb tailocin locus in a draft BC0425 genome.  32 
The BceTMilo locus was syntenic and highly similar to a 24.6 kb region on chromosome 1 of B. 33 
cenocepacia J2315 (BCAL0081 to BCAL0107). A close relationship and synteny were observed 34 
between BceTMilo and Burkholderia phage KL3, and by extension to the paradigm temperate 35 
myophage P2. Deletion mutants in the gene cluster encoding enzymes for biosynthesis of 36 
lipopolysaccharide (LPS) in the indicator strain B. cenocepacia K56-2 conferred resistance to 37 
BceTMilo. Analysis of the defined mutants in LPS biosynthetic genes indicated that α-D-glucose 38 
residue in the core oligosaccharide is the receptor for BceTMilo.  39 
IMPORTANCE 40 
 BceTMilo, presented in this study, is a broad host range tailocin active against Burkholderia spp. 41 
As such, BceTMilo and related or modified tailocins, have potential as bactericidal therapeutic 42 
agents against plant and human pathogenic Burkholderia. 43 
  44 
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INTRODUCTION 45 
 The Burkholderia cepacia complex (Bcc) is a group of gram-negative bacterial species, most 46 
of which are found in the natural environment and are not pathogenic to healthy humans. Some 47 
of these species, however, are opportunistic pathogens and pose serious risks to the health of 48 
persons with cystic fibrosis (CF) (1, 2). Among Bcc species, Burkholderia cenocepacia, 49 
especially the ET12 epidemic strain, is more commonly associated with cepacia syndrome, a 50 
rapidly progressing and usually fatal necrotizing pneumonia (3, 4). Most clinically relevant Bcc 51 
strains have demonstrated broad-spectrum antibiotic resistance in vitro (5). Even with a 52 
combination of antibiotics, clearance of infection is not generally observed (6). There is a 53 
substantial need to develop new strategies for antimicrobial therapy against this group of 54 
pathogens.    55 
 One potential strategy is the use of tailocins, or phage-tail like bacteriocins (7). These large 56 
bactericidal structures, first identified as R-type and F-type pyocins produced by Pseudomonas 57 
aeruginosa, resemble phage tails, with the R-type pyocins corresponding to the contractile tails 58 
of myophages such as T4 and the F-type pyocins corresponding to the flexible, non-contractile 59 
tails of siphophages such as T1. Similar bactericidal complexes were identified in many other 60 
bacterial genera (8-10). Recently, the term tailocin has been coined both to highlight the 61 
similarity to phage tails and to avoid confusion with the small molecule bacteriocins (11).  By 62 
extension, tailocins with contractile-tail or flexible tail morphologies are designated as 63 
myotailocins and siphotailocins, respectively. Both types of tailocins reproduce the initial steps 64 
of a phage infection cycle. After specific adsorption to a phage receptor, there is a 65 
conformational change in the tail structure, resulting in the puncturing of the host cytoplasmic 66 
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membrane, massive ion release and collapse of the proton motive force. This conformational 67 
change is most dramatic in the myotailocin, with the tail sheath contracting, forcing the tail tube 68 
through the outer membrane of the host and leading to a puncturing of the inner membrane.  In 69 
phage infections, ejection of the viral DNA into the cell is followed by resealing of the inner 70 
membrane lesion, thus allowing resumption of macromolecular synthesis and the progression of 71 
the infection cycle. By contrast, tailocins do not inject DNA, there is no-resealing event, and the 72 
cells never recover from the puncturing event, resulting in single-hit, non-lytic lethality.  73 
 Studies in the early 1970s showed that Pseudomonas myotailocins could be effective as 74 
antimicrobial agents of peritonitis in mice (12, 13). However, R-type pyocins exhibit narrow 75 
bactericidal spectra (14) and the diversity of tail fibers observed in other systems has shown that 76 
tailocins in general have a narrow host range (10). Myotailocins were recently engineered (15, 16) 77 
to extend their host range by replacing the C-terminal domain of the tailocin tail fiber (11, 14).  78 
Despite the extensive literatures on bacteriocins, little has been reported about Burkholderia 79 
bacteriocins and tailocins. Gonzalez and Vidaver (17) first reported bacteriocin production from 80 
a small set of B. cepacia strains. In a larger study that included 373 isolates from plants, clinical 81 
or environmental sources, Govan and Harris (18) developed a typing system based on 82 
susceptibility and production of bacteriocins for B. cepacia and identified two myotailocins by 83 
electron microscopy. More recently, a report addressing the ecological interaction of P. 84 
aeruginosa and members of the Bcc, which often co-infect patients with CF described that the 85 
majority of P. aeruginosa inter-specific inhibitory activity was due to the production of 86 
myotailocins (19). We report here on the isolation and characterization of a broad host range 87 
tailocin from a strain of B. cenocepacia and the identification of its cell surface receptors. 88 
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MATERIALS AND METHODS 89 
Bacterial isolates and culture conditions.   Bacterial strains and plasmids used in this study are 90 
listed in Table 1. The panel of 20 Burkholderia isolates included 18 B. cenocepacia isolates 91 
(seven members of the ET-12 lineage, three of the Mid-West clone, eight of the PHDC clone 92 
(10)) and one each of B. cepacia and Ralstonia pickettii, were listed in Table S1.  The seventy-93 
three Bcc isolates and the three B. gladioli isolates used in sensitivity testing were stock cultures 94 
from the U.S. Burkholderia cepacia Research Laboratory and Repository (Ann Arbor, MI; Table 95 
S2). Burkholderia glumae isolates used in the study were obtained from rice field samples, in 96 
Texas, expressing bacterial panicle blight symptoms (Gonzalez, unpublished; Table S2). 97 
Tryptone nutrient broth (TNB) (20, 21) was used for liquid culture. Tryptone nutrient agar (TNA) 98 
used for routine maintenance of cultures was identical to TNB except it lacked KNO3 and was 99 
supplemented with 20 g l–1 agar. TNA soft agar (TNSA) (TNA with 7.5 g l-1 agar) was used for 100 
overlays. Luria-Bertani (LB) medium was used in mating experiments (22). For counter-101 
selection, co-integrants were grown in Yeast-Tryptone (YT) broth, which consisted of 10 g l–1 of 102 
tryptone and 10 g l–1 of yeast extract in deionized water. Sucrose was added to YT broth at a 103 
final concentration of 15% w/v and supplemented with 20 g l–1 agar (YTA) to resolve co-104 
integrants. All Burkholderia spp, Escherichia coli, and P. aeruginosa strains were grown at 37°C 105 
in both liquid and solid medium unless stated otherwise. Antibiotics were added to the media at 106 
the following concentrations: 600 µg ml–1 kanamycin (Km) and 20 µg ml–1 tetracycline (Tc) for 107 
B. cenocepacia; 30 µg ml–1 Km for E. coli, respectively. 108 
Tailocin induction study.  For a typical small batch UV induction, strain BC0425 was grown on 109 
a TNA plate overnight at 37ºC.  A suspension was made and used to inoculate 20 ml TNB (A600 110 
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= 0.08) and grown with shaking (180 rpm) at 37ºC to A600 = 0.5. The cells were pelleted by 111 
centrifugation (10,000 X g for15 min at 5°C), washed once with 0.85% w/v NaCl, repelleted and 112 
resuspended in 10 ml of 0.85% w/v NaCl. The suspension was poured into a sterile 100 mm X15 113 
mm Petri dish and with lid off exposed to UV for 7 sec (360 μw cm-2 sec-1) in a Class II biosafety 114 
hood. Ten ml of 2XTNB and 30 ml of TNB were added to the treated and untreated control cells 115 
to make the final volume 50 ml. The cultures were returned to 37°C with shaking at 150 rpm. 116 
Growth of the culture was monitored using a Nephelo culture flask. When A600 decreased below 117 
0.2 for the UV-treated culture, DNaseI was added to a final concentration of 2 U ml–1 and the 118 
cultures were shaken at 37°C for an additional 30 min. Cell debris was removed by 119 
centrifugation (17,418 X g for 30 min at 5ºC) followed by filtration through a 0.22 µm filter 120 
(Millipore, Billerica, MA). Production of pyocins R1, R2 and R5 for spot sensitivity testing was 121 
accomplished by UV induction in the same way as described above. Lysates were titered as 122 
described below using strain PC184 or PAO1wbpM as indicators for tailocin BceTMilo and R 123 
pyocins, respectively. To calculate the burst size, the CFU was determined prior to UV exposure 124 
and the number of tailocin particles produced was estimated based on Poisson-distribution killing 125 
assay, as described below. The tailocin burst size was calculated as total killing units (KU) 126 
divided by number of cells at the time of UV induction.  127 
 128 
Tailocin activity assay. The antimicrobial activity of the tailocin was determined semi-129 
quantitatively by a spot dilution method.  Briefly, serial dilutions (twofold, fivefold or tenfold) of 130 
tailocin preparations were prepared in P-buffer (100 mM NaCl, 8 mM MgSO4, 50 mM Tris-HCl 131 
pH 7.5) and 10 µl of each dilution was spotted on TNA plates that had been overlaid with TNSA 132 
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seeded with approximately 107 CFU ml–1 of an indicator bacterium. After incubation for 18 h at 133 
37ºC the plates were evaluated for zones of inhibition. The reciprocal of the highest dilution that 134 
formed a visible inhibition zone was defined as the relative activity in arbitrary units (AU).   135 
Quantitative tailocin activity assays were performed using a Poisson-distribution killing 136 
method, adapted from Williams et al. (14), originally described by Kageyama et al. (23). Briefly, 137 
tailocin serial dilutions in P-buffer were added to 109 CFU ml-1 target bacteria in TNB and 138 
incubated for 40 min at 37oC in triplicate. The samples were then serially diluted and plated on 139 
TNA to count surviving bacteria. The number of tailocin particles is related to the fraction of 140 
bacterial survivors in a Poisson distribution, m = -ln(S), where m is the possible average number 141 
of lethal event (i.e., adsorbed tailocin particles) per bacterial cell, and S is the fraction of 142 
survivors. The total number of active particles ml–1 = m x cells ml-1 was defined as the KU ml–1, 143 
and is based on the assumption that in each sample, adsorption was quantitative within the 40 144 
min incubation period.  145 
 146 
Large scale tailocin production and purification.  The method of Scholl et al. (7) was used for 147 
large-scale preparation. Briefly, ammonium sulfate was slowly added to the filter-sterilized 148 
tailocin lysate to a final concentration of 40% (w/v) with stirring on ice. After 18 h at 5ºC, the 149 
ammonium sulfate precipitate was pelleted by centrifugation at 17,418 X g for 1 h at 5ºC and the 150 
pellet was resuspended in 1/10 of the original volume in cold TN50 (10 mM Tris, pH7.5, 50 mM 151 
NaCl) buffer. The suspension was dialyzed overnight against TN50 buffer using a Slide-A-152 
Lyzer® dialysis cassette (3.5 kDa MWCO; Pierce). The tailocin particles were sedimented at 153 
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90,619 X g for 2.5 h at 5ºC using a Beckman type 60Ti rotor; the pellet was resuspended in P-154 
buffer and titered for activity as described above.   155 
 156 
Preparative Isoelectric Focusing.  For purposes of imaging and protein analysis, further 157 
purification was performed. Preparative isoelectric focusing (IEF) generated acceptably pure 158 
tailocin preparations. For IEF, 200 ml of an UV induced tailocin lysate was concentrated by 159 
ultracentrifugation (90,619 X g for 2.5 h at 5ºC) using a type 60Ti rotor in a Beckman L8-70 M 160 
ultracentrifuge.  The pellet was resuspended in 2.5 ml sterile ultrapure water (Invitrogen) 161 
containing 0.3% (w/v) octylglucoside and 5% (v/v) glycerol. Three ml of Bio-Rad Ampholyte 162 
(3-10) was added to a buffer containing 3M Urea, 0.3% octylglucoside, and 0.3% (w/v) CHAPS 163 
(3-[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate) to a final volume of 50 ml. 164 
Anion exchange membranes were equilibrated in 0.1 M NaOH and cation exchange membranes 165 
in 0.1 M H3PO4. The tailocin preparation was applied to a Rotofor chamber (BioRad) that had 166 
been pre-focused at 15 W constant power for 1 h. The chamber was run at 15 W at 4ºC until the 167 
current stabilized. The pH of each fraction (~20 fractions) was determined.  The fractions were 168 
adjusted using 1 M Tris-HCl pH 7.0 to a final concentration of 0.1 M, and the activity was 169 
measured by spot-dilution method as described above.  170 
 171 
Electron microscopy.  IEF purified tailocin sample (2 X 1011 KU ml–1) diluted 1:5 in P-buffer 172 
was negatively stained for transmission electron microscopy (TEM) as described by Ahern et al. 173 
(21). Specimens were observed on a JEOL 1200EX TEM (Microscopy and Imaging Center, 174 
Texas A&M University) operating at an acceleration voltage of 100 kV. Images were recorded at 175 
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
9 
 
calibrated magnifications by a charge-coupled device (CCD) camera, and measurements were 176 
acquired using Image J software.  177 
 178 
Effects of heat and enzyme treatments.  The temperature stability of tailocin BceTMilo was 179 
assessed by heating a large-scale purified tailocin preparation (1010 KU ml–1) to 50ºC and 80ºC 180 
for 60 min, or 100ºC for 3 and 10 min.  Samples were immediately chilled on ice after heating 181 
and assayed for activity by the spot-dilution assay as described above.   182 
Enzymatic stability of the tailocin to trypsin (131,000 U mg–1), α-chymotrypsin (83.9 U mg–183 
1), proteinase K (34 U mg–1), protease (4 U mg–1), lipase (20,000 U mg–1), papain (24 U mg–1), or 184 
lysozyme (70,000 U mg–1) were assayed using conditions previously described by Gonzalez & 185 
Kunka (Gonzalez & Kunka, 1987). All enzymes were purchased from Sigma. Tailocin 186 
preparations (1010 KU ml–1) were incubated with each enzyme at a final concentration of 500µg 187 
ml–1.  Enzyme treatments with α-chymotrypsin and trypsin were performed at 25ºC for 60 min, 188 
with all other enzyme/tailocin mixtures incubated at 37ºC for 60 min.  Tailocin activity, after 189 
incubation with individual enzymes, was assayed as described above. 190 
 191 
pH stability.  Tailocin prepared using the large-scale method was dialyzed against buffers 192 
ranging from pH 2-10 using a Slide-A-Lyzer® dialysis cassette (3.5 kDa MWCO).  The tailocin 193 
solution was dialyzed for 18 h with two exchanges against each of the following buffers: 0.05 M 194 
glycine hydrochloride buffer (pH 2.04), 0.05 M citrate buffer (pH 4.78), 0.05 M Tris-HCl buffer 195 
(pH 6.8 and 8.8), and 0.05 M carbonate-bicarbonate buffer (pH 10.64). The control was dialyzed 196 
against P-buffer.  The contents were then serially diluted with P-buffer and assayed for activity 197 
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as described above. All buffers were spotted to overlays to confirm killing activity was not due 198 
to buffer activity. 199 
 200 
SDS-PAGE.  The major proteins of tailocin BceTMilo were separated using SDS-PAGE gel 201 
electrophoresis. Eight µg of IEF purified tailocin sample were added to 20 µl of SDS loading 202 
buffer [50 mM Tris-HCl (pH 7.5) with 0.01 g of SDS, 1.54 mg of dithiothreitol, and 0.1 mg m1-1 203 
of bromophenol blue], heated at 95°C for 5 min, and applied to either a 7.5% or a 10-20% 204 
gradient Tris-HCl Mini-PROTEAN gel (BioRad, Hercules, CA). Electrophoresis was carried out 205 
at 200 V (constant) as described by Laemmli (24). Precision Plus protein standard (Bio-Rad/161-206 
0374) was used as a standard. The gels were stained with Coomassie Brilliant Blue R250 207 
(BioRad).    208 
 209 
Liquid Chromatography-tandom Mass Spectrometry (LC-MS/MS) analysis. To conduct 210 
LC-MS/MS analysis of the tailocin major proteins, the 43 kDa and 17 kDa protein bands were 211 
excised from a 10-20 % Tris-HCl gel, and the 100 kDa and 30 kDa bands were excised from a 212 
7.5% SDS Tris-HCl gel. The proteins were subjected to LC-MS/MS analysis on a Q-TOF 213 
Premier Mass Spectrometer (University of Michigan Biomedical Core Facility- Proteomics and 214 
Peptide Synthesis Core).  Protein LynX global Server and Mascot search engines were used to 215 
search the SwissProt (http://ca.expasy.org/sprot) and NCBI databases 216 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) (25, 26). 217 
 218 
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DNA manipulations.  Genomic DNA was extracted using a DNeasy kit (Qiagen, Valencia, CA), 219 
plasmid DNA was prepared using a Miniprep kit (Qiagen), gel extractions and PCR product 220 
purification were conducted using a Qiaquick gel extraction kit and Qiaquick PCR purification 221 
kit, respectively, according to manufacturer’s instructions (Qiagen).  All restriction 222 
endonucleases, Taq DNA polymerase, and T4 DNA ligase were purchased from New England 223 
Biolabs (Ipswich, MA) and were used according to manufacturer instructions.  Oligonucleotide 224 
primers were synthesized by Integrated DNA Technologies (Coralville, Iowa).  DNA sequencing 225 
was performed at the Institute of Developmental and Molecular Biology, Gene Technologies 226 
Laboratory at Texas A&M University.  227 
 228 
Sequencing assembly and annotation of BceTMilo genes.  To understand the genetic 229 
organization of BceTMilo, BC0425 genomic DNA was isolated using modifications of the 230 
CTAB method (27).  BC0425 DNA was sequenced using 454 genome sequencing technology 231 
(Duke University, Institute for Genome Sciences & Policy). Sequence information was 232 
assembled into contigs using the Newbler sequence assembly program (Roche, USA).  233 
Genemark http://exon.biology.gatech.edu/gmhmm2_prok.cgi) was used to predict all possible 234 
open reading frames.  To annotate contig 77, which contains the BceTMilo genes, Genemark 235 
(http://exon.gatech.edu/GeneMark/heuristic_gmhmmp.cgi) was first used to identify all possible 236 
ORFs (28).  The Artemis Comparison Tool (Sanger Centre) was then used to identify the most 237 
likely start codon for each ORF, by searching for the presence of a potential ribosomal binding 238 
site (RBS) (29). Each identified ORF was then compared to the NCBI protein database using 239 
Blastp (https://blast.ncbi.nlm.nih.gov/Blast.cgi) to assign putative functions (25). InterProScan 240 
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(http://www.ebi.ac.uk/Tools/webservices/services/interproscan), LipoP 241 
(http://www.cbs.dtu.dk/services/LipoP/), and TMHMM 242 
(http://www.cbs.dtu.dk/services/TMHMM/) were used to identify conserved domains, 243 
lipoprotein processing signals, and transmembrane domains (TMDs), respectively.  Genome 244 
maps were drawn utilizing the programs DNA Master 245 
(http://cobamide2.bio.pitt.edu/computer.htm) and Inkscape (https://inkscape.org/en/). 246 
 247 
Lipopolysaccharide extraction.  Lipopolysaccharides (LPS) extracts from tailocin sensitive and 248 
resistant strains were obtained using the hot phenol method as described by Apicella et al. (30). 249 
The dry weight of purified LPS was determined and resuspended in endotoxin free water (Sigma) 250 
to a concentration of 1-2 µg/ml.   251 
 252 
Electrophoretic analysis of LPS.  LPS samples were analyzed using the Laemmli SDS-gel 253 
electrophoresis system (24). LPS preparations were dissociated in SDS loading buffer and heated 254 
at 90-100ºC for 5 min.  LPS was resolved by running 1.0 µg of each extract on a 16.5% Tris-255 
Tricine SDS mini-gel (Bio-Rad) for 6 h at 60 volt and visualized by silver staining (31).   256 
 257 
LPS adsorption assay. A LPS adsorption assay was performed using a purified tailocin 258 
preparation (1011 KU ml–1). The tailocin preparation was diluted (1:10) with P-buffer amended 259 
with 5mM CaCl2 (PC-Buffer) and mixed with increasing amounts of LPS preparations. After 260 
incubation at 37ºC for 30 min, the mixtures were assayed for activity by spotting a 1:2 dilution 261 
series on overlays seeded with B. cenocepacia strain PC184, as described above.  262 
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Sugar inhibition assay. The sugar inhibition assay was performed as described by Dawes (32) 263 
with minor modifications. The effects of D-galactose, α-D-glucose, D-fructose, D-Mannoheptose, 264 
L-rhamnose, D-cellobiose, lactose, sucrose, and D-raffinose on the adsorption of tailocin 265 
BceTMilo to strain PC184 were tested. Strain PC184 was grown in 1 L TN broth (200 rpm) to an 266 
A600 = 1. Cells were centrifuged (10,000 X g) at 4°C for 5 min. The cells were washed in 40 ml 267 
P-buffer, centrifuged, and then resuspended in 4 ml P-buffer. Two ml of the bacterial suspension 268 
(1011 cells ml–1) was mixed with 500 µl of tailocin BceTMilo (109 KU ml–1) and 2.5 ml of 1.2 M 269 
sugar (final concentration of 0.6 M). The mixture was incubated at 37°C and 500 µl samples 270 
were taken at 0, 1, 3, 6, and 9 min post mixing.  Samples were immediately centrifuged and 271 
supernatants were filter sterilized. The remaining tailocin activity of the samples was determined 272 
using a spot assay. The percentage of unadsorbed tailocins was calculated by dividing the titer of 273 
each sample by the titer of the buffer control. 274 
 275 
Construction of deletion mutants in B. cenocepacia BC0425 and K56-2. Deletion of recA in 276 
the BceTMilo producer strain BC0425, and the waaL and waaC in indicator strain K56-2 were 277 
performed using the system developed by Hamad et al. (33), except that the constructed suicide 278 
vectors (pMo130::recA-UD, pMo130::waaL-UD  and pMo130::waaC-UD ) were introduced into 279 
B. cenocepacia strain BC0425 or K56-2 by conjugation using tri-parental mating with pRK2013 280 
as the mobilizing plasmid. In brief, donor, mobilizer, and recipient suspensions were made in LB 281 
broth from cultures grown on solid media under selective conditions, as appropriate for 18 h.  282 
Bacterial suspensions were adjusted spectrophotometrically to A600= 0.5, mixed at an equal ratio 283 
(1:1:1), and transferred to a positively charged sterile membrane layered on a 100 x 15 mm LB 284 
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agar petri dish.  Following an 18 h incubation period at 37°C, the cells from the mating and 285 
respective controls were washed twice in phosphate buffer (0.125 M, pH 7.1) by centrifugation 286 
(12,096 X g for 10 min at 5°C).  The bacterial pellets were resuspended in phosphate buffer and 287 
dilutions were plated on LB agar plates amended with 600 µg ml-1 Km and 20 µg ml-1 Tc for 288 
selection of single crossover events. PCR primers for regions flanking recA were designed based 289 
on the annotated sequence of BC0425. Since B. cenocepacia strain K56-2 is clonally related to 290 
the sequenced strain J2315 (34, 35), PCR primers for regions flanking waaL and waaC in strain 291 
K56-2 were designed based on J2315 sequences BCAL2404 to BCAL2406 and BCAL3111 to 292 
BCAL3113, respectively (www.sanger.ac.uk/Projects/B_cenocepacia/). Primers used for 293 
constructing the suicide vectors (pMo130::recA-UD, pMo130::waaL-UD  and pMo130::waaC-294 
UD) were listed in Table 2.. The deletions of the respective genes were confirmed by PCR.  295 
 296 
In-trans complementation of BC0425 and K56-2 mutants.  Plasmids pMo168::recA-comp, 297 
pMo168::waaL-comp and pMo168::waaC-comp were constructed as replicative vectors for in-298 
trans complementation of BC0425 Δ recA, K56-2 Δ waaL and K56-2 Δ waaC mutants, 299 
respectively. Plasmids were introduced into the deletion mutants by tri-parental mating as 300 
described above. Primers used for amplifying the wild-type recA, waaL and waaC were listed in 301 
Table 2. The presence of the wild-type recA, waaL and waaC were confirmed by PCR. 302 
 303 
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Nucleotide sequence accession number. In accordance with Texas A&M Center for Phage 304 
Technology policy, the tailocin from B. cenocepacia BC0425 was designated BceTMilo 305 
(https://cpt.tamu.edu). The genome was deposited in GenBank under the following accession 306 
number: KY316063. 307 
 308 
RESULTS 309 
Identification, induction and morphology of tailocin BceTMilo. In the process of screening   310 
for tailocins active against members of the Bcc, it was observed that B. cenocepacia BC0425 311 
produced small clear zones of inhibition on overlays of 11/20 panel indicator isolates (Table S1). 312 
Cultures of BC0425 induced with UV light underwent lysis and produced ~5 X 1010 KU/ml-1, 313 
indicating with the presence of an inducible tailocin locus (36, 37, 38). Tailocins could be 314 
purified and concentrated by ammonium sulfate precipitation followed by ultra-centrifugation, 315 
achieving yields of ~40% and final titers of ~5 X 1011 KU ml-1.  316 
The tailocins further purified by preparative isoelectric focusing and visualized by 317 
transmission electron microscopy, displayed the characteristic morphology of R-type pyocins of 318 
P. aeruginosa (37). Electron micrographs of purified tailocin showed both uncontracted (~87.4%) 319 
and contracted (~12.6%) particles (Fig. 1A).  The uncontracted particles were 141 ± 3.5 nm by 320 
17± 1 nm rods, with a baseplate and several tail fibers visible in the electron micrograph (Fig. 1B, 321 
arrows), and ~33-34 rings of sheath proteins, as estimated by direct counting (not shown).  Some 322 
particles were contracted, resulting in a shortening and thickening of the sheath (55 nm x 23 nm) 323 
and the exposure of a 140 nm x 8 nm tail tube (Fig. 1A). Based on the morphology, the 324 
myotailocin was designated as BceTMilo, where “Bce” indicates the host (B. cepacia), “T” 325 
designates tailocin (rather than phage), and Milo is the assigned name to the locus (based on our 326 
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convention that the names for phage and phage-derived particles with contractile, flexible or 327 
short/stubby tails begin with M (myo), S (sipho) and P (podo), respectively (https://cpt.tamu.edu). 328 
 329 
Characterization of the myotailocin BceTMilo. Purified BceTMilo did not lose killing activity 330 
when exposed to trypsin, α-chymotrypsin, proteinase K, protease, lipase, papain, or lysozyme, 331 
consistent with other tailocins (38). BceTMilo killing activity was stable for 1 h at 50ºC, but was 332 
lost after 1h at 80ºC, or 3 min at 100ºC; when stored at 4-8 0C, the killing activity had ~ 50% loss 333 
over a six-month period. Tailocin killing activity was stable between pH 4.8 - 8.8, with a 100-334 
fold decrease in activity after 18 h at pH 10.5 and all detectable activity lost after 18 h at pH 2.0.   335 
SDS-PAGE analysis of IEF-purified tailocin revealed four major protein subunits of 17, 30, 336 
43 and 100 kDa (Fig. 2A&2B). For myotailocins, which have similar structures to the tails of 337 
myophages like T4, the two most numerous species should be the sheath and tube proteins, 338 
which typically have ~40 kDa and ~20 kDa molecular masses (39) corresponding to the 43 kDa 339 
and 17 kDa species (Fig. 2A).  Given the 33-34 rings of sheath proteins as determined above, 340 
both sheath and tube proteins should be present at ~200 molecules per tailocin particle.   341 
Densitometry analysis of the 43 kDa and 17 kDa tailocin protein species allowed quantification 342 
of tailocin particles and a calculation of their killing efficiency (Table 3). Based on this, given 343 
the limitations of Coomassie Blue staining, we estimated an average efficiency of killing (EOK) 344 
of ~0.5 (Table 3). This strongly indicates that BecTMilo kills bacterial targets by the same 345 
single-hit killing mechanism characterized for other myotailocins (7). Based on this estimate, it 346 
is possible to approximate that induced cells on average produce 620 +/- 30 KU or particles cell-1 347 
(Table 4).  348 
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Mapping and features of the BceTMilo defective prophage. To determine the genetic locus 349 
encoding the tailocin, a draft genome of strain BC0425 was compared to peptide sequences 350 
obtained from LC-MS/MS analysis of the tail sheath and tube proteins, as well as from the two 351 
minor proteins.  All four proteins could be mapped to a 23 kb contig of the draft genome (Fig. 352 
3A), which contained 30 predicted phage-related genes (Table S3). The same element was found 353 
in the fully annotated genome of B. cenocepacia J2315 (Fig. 3A) and many other Bcc strains 354 
(Fig. S1), with the J2315 locus sharing >99% sequence identity over most of the genes, except 355 
for a 1.9kb insertion, identified as a group II intron, between genes 8 and 9 (Fig. 3A). 356 
A syntenic arrangement of genes was also found in the Bcc myophage KL3 (40), a phage 357 
obtained as a spontaneous plaque-former in a lawn of its own lysogen; KL3 is shown in its 358 
prophage form in Fig. 3B. The morphogenesis genes of KL3, and thus also BceTMilo, are 359 
mostly syntenic to the well-studied paradigm temperate myophage P2 of E. coli (Fig. 3B), 360 
making it possible to assign the function of most of the tailocin genes.  For example, BceTMilo 361 
genes 16 and 17, which encode the 17KDa and 43KDa major tailocin species, correspond to the 362 
tail tube and sheath genes of KL3 and P2. Also, the genes encoding the 100 kDa and 30 kDa 363 
minor species of the tailocin are syntenic to the tail fiber and tail fiber chaperone genes of KL3 364 
and occupy the same positions in the late gene transcript pattern as the same but unrelated genes 365 
in P2 (Fig. 3B). As expected, the BceTMilo locus lacks the distal end of the KL3 prophage 366 
containing the head morphogenesis and DNA modification genes.  Remarkably, the breakpoint 367 
in synteny between the tailocin locus and the morphogenesis gene region of KL3 and P2 is 368 
between the most distal tail protein, the tail completion protein X, and the first capsid protein, the 369 
head completion protein L. The only tail morphogenesis gene present in KL3 and P2 but missing 370 
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in the tailocin locus is gene S, which was apparently deleted along with a moron element (41) 371 
encoding a DNA methylase inserted in the antisense orientation within the tail morphogenesis 372 
genes. In P2, the S protein appears to fulfill the role of an adaptor required to allow the 373 
completed tail to dock with the filled capsid (42) a function not required for a tailocin. Overall, 374 
all the BceTMilo proteins involved in tailocin morphogenesis are also similar to the equivalent 375 
genes in the P. aeruginosa R-type pyocin locus, except for the tape measure and the tail fiber, 376 
and the associated chaperones (not shown).  377 
BceTMilo and KL3 also have very similar lysis genes including a type I holin (gp29), a 378 
putative antiholin with four predicted TMDs (gp28), and the two spanin subunits (gp25 and 26 379 
for the i-spanin and o-spanin subunit, respectively), as described by Lynch et al (40). These lysis 380 
genes are unrelated to the P2 functional equivalents. 381 
Combining synteny and sequence similarity, every BceTMilo gene could be assigned a 382 
counterpart in KL3, except for genes 1 and 2. gp1 encodes a tyrosine integrase with strong 383 
similarity to the P2 Int, but was not detectably related to gp1 of KL3, also an integrase of the 384 
same family.  The overlap of gene 2 with the integrase gene and the fact that its product has 385 
winged-helix DNA binding motifs suggest that gp2 encodes a Xis protein required for prophage 386 
excision.  The only gene that cannot be robustly assigned a function is gene 3, which has a 387 
homolog in a similar Burkholderia phage BEK (Database: GenBank Entry: CP008753). The 388 
corresponding ORF in KL3 was not previously annotated and was assigned gene 2a in Fig. 3B.   389 
BceTMilo shares its late gene regulation system with KL3 and P2, since all three encode the 390 
well-characterized Ogr transcription factor (43).  The genes involved in lysogenic regulation of 391 
the KL3 prophage have not been precisely defined, but gp 9 of the BceTMilo tailocin locus was 392 
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closely related to gp13 of KL3 and encodes a CI-like repressor. Induction of BceTMilo was 393 
determined to be RecA dependent, as UV induction of the BC0425 Δ recA resulted in no 394 
production of the tailocin or lysis of cells in parallel experiments where the in- trans complement 395 
[ BC0425 Δ recA (pMo168:: recA-comp)] produced near parental levels of tailocin as determined 396 
by spot-titer method (data not shown). 397 
Comparison of BceTMilo with the tailocin locus in J2315 showed that in addition to the 1.9 398 
kb group II intron insertion between the two regulatory genes for J2315 tailocin, there was a 36 399 
bp insertion in the J2315 version of the tail fiber assembly gene, resulting in the expansion of 400 
Ser-Glu-Pro motif repeats already present in BceTMilo; this motif expansion lies in a position 401 
expected to influence host range. Moreover, there were a total of 121 single nucleotide 402 
polymorphisms (SNPs) over the 23 kb sequence.  Most of the SNPs were shown in gaps between 403 
genes. All of the SNPs in genes preserved the reading frame; i.e., all were either silent or were 404 
missense changes. Out of 30 missense SNPs, only 3 were detected in hypothetical genes of 405 
unknown function; others were in structural genes or in lysis cassettes. For example, there were 7 406 
SNPs in the tail fiber gene and 8 SNPs in the tape measure protein detected, which represented 407 
5.2 kb of the locus; and 2 and 3 SNPs were found in i-spanin/o-spanin and endolysin genes, 408 
respectively. Tailocin activity has not been reported for J2315, which contains the fully 409 
functional BcepMu prophage (44). However, negative-stain electron microscopy of concentrated 410 
lysates obtained from UV-induction of J2315 revealed low numbers of tail-like structures 411 
indistinguishable from the BceTMilo particles for which we were unable to find a sensitive host 412 
among 41 Bcc strains tested.  Nevertheless, the stringent conservation of all the structural genes 413 
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suggests that the tailocin encoded in J2315 may contribute to fitness, and thus may be functional 414 
but with a different host range dictated by the repeat expansion in the tail fiber assembly gene. 415 
 416 
Inhibitory spectrum of tailocin BceTMilo.  To determine the inhibitory spectrum of the 417 
tailocin, a panel of 101 Burkholderia species was tested for sensitivity, using both broth micro-418 
dilution and spot assays. Of the 73 isolates representative of the species belonging to the Bcc, 50 419 
were sensitive to BceTMilo (Table S2), with 59% of B. cenocepacia isolates tested exhibiting 420 
sensitivity.  The non-Bcc Burkholderia species assayed, B. gladioli and B. glumae, showed high 421 
sensitivity (93%; Table S2). Overall 76% of Burkholderia species tested were sensitive to 422 
tailocin BceTMilo. A subset of the same Burkholderia isolates panel were spot tested for the 423 
susceptibility to pyocins R1, R2 or R5, only 0/47, 1/47 and 4/47 were sensitive to each of the 424 
respective pyocins (Table S2).  425 
 426 
LPS determinants as receptors for BceTMilo. To determine the nature of the receptor for 427 
tailocin BceTMilo, LPS adsorption assays were conducted. LPS from a sensitive strain (PC184) 428 
and a resistant strain (AU10487) was extracted and used for the assay. Tailocin activity 429 
decreased in mixtures with increasing concentrations of LPS from the sensitive strain (Fig. 4A), 430 
whereas no decrease in activity was observed in mixtures with increasing concentration of LPS 431 
from the resistant strain (Fig. 4B), indicating that the receptor for BceTMilo was part of the LPS 432 
of the sensitive strain. 433 
Since a sugar moiety(s) of LPS could be involved in adsorption of tailocin BceTMilo, a sugar 434 
inhibition assay was conducted.  Sugars α-D-glucose, L-rhamnose, and D-manno-heptose were 435 
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chosen for evaluation since they are components of B. cenocepacia LPS (45, 46). Sugars α-D-436 
glucose and α-L-rhamnose inhibited tailocin adsorption, whereas D-galactose and D-fructose had 437 
little or no effect on tailocin adsorption to sensitive cells (Fig. 5). The effects of di- and tri-438 
saccharides containing glucose were also investigated. Sucrose and raffinose, both with a α-1, 2 439 
glycosidic linkage, inhibited adsorption, whereas D-cellobiose and lactose, both with a β-1, 4 440 
glycosidic linkage, showed only minor inhibition (Fig. 5).  441 
Kohler et al. (47) have proposed that LPS plays an essential role both as a protective shield 442 
and as a receptor for R-pyocins of P. aeruginosa. Using genetically defined LPS mutants, they 443 
showed that the L-rhamnose residue was the receptor for R1 in P. aeruginosa and that two 444 
distinct D-glucose residues of the outer core were part of the receptor sites for R2- and R5-445 
pyocins. We demonstrate here that P. aeruginosa strain PAO1 exhibited slight sensitivity to 446 
tailocin BceTMilo (Fig. 6A (i), 6B (i), zones not clearly visible), whereas the PAO1 wbpM 447 
mutant derivative, deficient in B-band, showed increased sensitivity to tailocin BceTMilo (Fig. 448 
6A (ii), 6B (ii)). The wbpL derivative of PAO1, deficient in both LPS B-band and A-band, and a 449 
PAO1 rmlC devoid of L-rhamnose, but containing an α-glucose residue, were both sensitive to 450 
BceTMilo (Fig. 6A (iii), 6B (iii), 6A (iv), 6B (iv)). However, an algC mutant, devoid of both an 451 
L-rhamnose and α-D-glucose residues exhibited no sensitivity to BceTMilo (Fig. 6A (v), 6B (v)), 452 
indicating that α-D-glucose is required for adsorption of tailocin BceTMilo in P. aeruginaosa.   453 
LPS mutants of the genetically malleable B. cenocepacia strain K56-2 and their complements 454 
were constructed in this study and their susceptibilities to BceTMilo were tested. LPS extracted 455 
from K56-2, J2315 or K56-2 deletion mutants, and their complements were compared using SDS 456 
gel electrophoresis. Deletion of the waaL, an O-antigen ligase, predicted a loss of the O-antigen 457 
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surface expression and the L-rhamnose in K56-2 (46), and deletion of waaC, a 458 
heptosyltransferase I, would result in a heptose-less mutant with a rough phenotype. A ladder-459 
like banding pattern, corresponding to the presence of polymeric O-antigen, was visible for strain 460 
K56-2, whereas J2315 was devoid of an O-antigen (Fig. 7, lanes 1 and 2, respectively) as was 461 
previously reported by Ortega (48). The absence of O-antigen ladder was observed in the K56-2 462 
Δ waaL preparation (Fig. 7, lane 3) and a severely truncated lipid-A-core region with the 463 
concomitant loss of O-antigen production was observed in the K56-2 Δ waaC mutant (Fig. 7, 464 
lane 4). The in-trans complementation of K56-2 Δ waaL restored O-antigen production (Fig. 7, 465 
lane 5) and in-trans complementation of K56-2 Δ waaC restored O-antigen production and lipid-466 
A core regions (Fig. 7, lane 6). Using the spot assay, we demonstrated that strains K56-2, J2315, 467 
and the K56-2 waaL deletion mutant (Δ waaL) were sensitive to tailocin BceTMilo (Fig. 8A (i), 468 
8A (ii) and 8A (iii)), but the Δ waaC mutant of K56-2 (Fig. 8A (iv), 8B (iv)). The 469 
complementation of K56-2 Δ waaL deletion did not change the sensitivity to BceTMilo (Fig. 8A 470 
(v)), but the complementation of K56-2 Δ waaC deletion restored the sensitivity to BceTMilo 471 
(Fig. 8A (vi)). 472 
  473 
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Discussion   474 
The Bcc and P. aeruginosa are significant opportunistic human pathogens in CF patients (35). 475 
Early lung infections in CF patients are most often due to P. aeruginosa; however, secondary 476 
infections caused by Bcc often give rise to a highly variable and unpredictable clinical outcome 477 
(49).  Previous studies have suggested that P. aeruginosa and Bcc actively affect each other’s 478 
growth through production of secreted products (50).  Several studies have been reported that 479 
most clinical and environmental P. aeruginosa strains produce pyocins (19, 51, 52), whereas 480 
there is only limited information concerning bacteriocins produced by Burkholderia species (16, 481 
17, 19). Bakkal et al. (4) noted that almost all P. aeruginosa isolates in their study were able to 482 
inhibit a wide range of P. aeruginosa and Bcc strains, whereas Bcc strains, on average, inhibited 483 
a much more limited number of strains.  484 
In this study, we identified and characterized the tailocin BceTMilo, which exhibited broad 485 
host activity among Burkholderia spp. Evaluation of BceTMilo showed that 68% of Bcc 486 
representing 10 species and 90% of non-Bcc Burkholderia strains tested were sensitive (Table 487 
S2). Additionally, tailocin BceTMilo had killing activity against P. aeruginosa PAO1 and 488 
derivatives.  489 
The observed average of 600 particles per cell of BceTMilo produced by B. cenocepacia 490 
strain BC0425 is three to six fold higher than the 100-200 particles/ cell reported for production 491 
of pyocin R2 by strain PAO1(7). In P. aeruginosa the RecA, PrtR (repressor protein) and PrtN 492 
(activator protein) co-regulate expression of R-, F-, and S-type pyocin genes that are induced in 493 
responses to such mutagenic agents as UV and mitomycin C (54) or oxidative stress (55). 494 
Genome-wide transcriptome analysis of P. aeruginosa has revealed that pyocins S-, F-, and R 495 
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transcripts are upregulated by oxidative stress as are lysis related genes, indicating that multiple 496 
pyocins are released upon induction (55). This coordinated transcription, translation and lysis of 497 
cells may limit the number of R-type pyocin particles produced per cell.  498 
The synteny and close relationship between BceTMilo, KL3 and, by extension, the paradigm 499 
temperate myophage P2 suggest that, other than regulatory genes, nothing more is needed to 500 
generate a tailocin other than the deletion of the head genes (Fig. 3B). Since every structural 501 
gene required for the P2 myophage tail has a homolog both in KL3 and in the tailocin locus, the 502 
simplest explanation could be that both BceTMilo myotailocin locus and the temperate 503 
myophage phage KL3 were derived from a common ancestor, with BceTMilo undergoing 504 
internal deletions of the head and DNA modification genes. 505 
Comparison of BceTMilo with a tailocin locus in the epidemic strain J2315 showed that more 506 
than 99% sequence identity in genes, with the exceptions of three areas. There was a 1.9 kb 507 
group II intron insertion between the two regulatory genes for J2315 tailocin, a 36 bp insertion in 508 
the J2315 version of the tail fiber assembly gene, and there were a total of 121 SNPs over the 23 509 
kb sequence. The group II intron insertion between the two regulatory genes may have affected 510 
transcription efficiency and that resulted in the observed low production of particles from J2315. 511 
The observed SNPs were dispersed throughout the J2315 tailocin cassette and did not result in 512 
frameshifts that would affect protein expressions. As might be expected, the largest observed 513 
difference between the BceTMilo and J2315 tailocin was in the tail fiber assembly gene, which 514 
determines the specificity of the two tailocins and therefore their host range spectrums. 515 
A critical feature for pyocins/tailocins is their ability to recognize and bind cell receptors 516 
specific to their host.  Different bacterial surface components act as the receptors for phages and 517 
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phage-tail like bacteriocins, including flagella (56), pili (57), outer membrane proteins such as 518 
OmpA and OmpC (58) and LPS (47, 59). LPS adsorprion assay showed that the activity of 519 
tailocin BceTMilo was neutralized by purified LPS from sensitive strains, but not from resistant 520 
strains (Fig. 4). Sugar inhibition assays indicated that L-rhamnose and sugars in which D-glucose 521 
was α-linked to another residue inhibited adsorption (e.g. sucrose or raffinose), whereas sugars 522 
with a β-linked D-glucose, as in D-cellobiose or lactose, did not inhibit adsorption (Fig. 5). This 523 
suggested that both α-D-glucose and L-rhamnose were the putative sugar components of the LPS 524 
involved in BceTMilo adsorption.  525 
Our evaluation of BceTMilo for activity against PAO1 and LPS mutant derivatives showed 526 
that the parental strain, expressing both the A-band and B-band O polysaccharides were less 527 
sensitive than PAO1wbpM (LPS A+ LPS B-) and PAO1wbpL (LPS A- LPS B-), indicating that 528 
removal of the B-band LPS exposed the receptor site for the BceTMilo. The PAO1 rmlC mutant 529 
lacking the LPS A and B bands and a terminal L-rhamnose, but containing a α-D-glucose residue 530 
was sensitive to BceTMilo, whereas the PAO1algC mutant, devoid of both bands as well as the 531 
terminal L-rhamnose and α-D-glucose residues was resistant, suggesting that α-D-glucose is a 532 
receptor for adsorption of tailocin BceTMilo in P. aeruginosa.  533 
The results obtained with PAO1 were correlated with the sensitivity patterns observed in B. 534 
cenocepacia J2315, K56-2 and its derivative LPS mutants (Fig. 8). J2315 contains a terminal α-535 
D-glucose and L- rhamnose and showed sensitivity to BceTMilo, as did K56-2 that contains an 536 
internal α-D-glucose in the core oligosaccharide and L- rhamnose as part of the O-antigen. The 537 
K56-2 Δ waaL mutant (O-antigen deficient) devoid of L- rhamnose exhibited sensitivity to 538 
BceTMilo, which argues against the role of L- rhamnose as a receptor, despite the sugar 539 
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inhibition data. Furthermore, the K56-2 Δ waaC mutant (O-antigen and α-D-glucose deficient) 540 
lacking the internal α-D-glucose was resistant to BceTMilo, which strongly suggests that α-D-541 
glucose either internal or terminal position is the receptor for the tailocin in K56-2 or J2315. 542 
The host range activity of tailocins is determined by their tail fibers and generally results in a 543 
narrow spectrum of killing activity (14, 16). Tailocin BceTMilo exhibited broad host activity 544 
among Burkholderia species and lineages (Table S2).  Bakkal et al. (19) noted that almost all P. 545 
aeruginosa isolates in their study were able to inhibit a wide range of P. aeruginosa and Bcc 546 
strains, whereas Bcc strains, on average, inhibited a much more limited number of strains, 547 
suggesting that bacteriocin-based inhibition may play a role in governing P. aeruginosa and Bcc 548 
interactions in the CF lung.  Our testing of 44 Bcc isolates, representing nine species using 549 
pyocins R1, R2 or R5 lysates indicate very limited activity by the R-pyocins toward the Bcc 550 
(Table S2).  Given that R2 encompasses the spectra of R3 and R4 (15, 60), we submit that all 551 
interspecific activity observed against the Bcc by Bakkal et al. (19) may not have been due to 552 
pyocin activity and may be a reflection of the isolates used in the study. Clearly more 553 
information is needed to determine the role tailocins play in the dynamics of microbial 554 
interactions.  555 
Tailocins have previously been recognized as potential anti-bacterial agents (7, 61). The 556 
disadvantage of tailocins is obviously the incapacity for proliferation at the site of therapeutic 557 
action, thus requiring delivery at high concentration. However, this disadvantage is somewhat 558 
compensated for by two fundamental aspects of tailocin character: the lack of DNA, thus 559 
ameliorating concerns related to the unintentional spread of genes through specialized or 560 
generalized transduction or the dispersion of recombinant genetic material; and the one-hit 561 
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killing character, which allows the definition of dose in pharmacological usage. A further, 562 
somewhat less obvious limitation has been the rather narrow host range of the well-described 563 
tailocins, which may be related to the fact that hosts carrying tailocin loci cannot rely on DNA-564 
based immunity for protection against the homotypic tailocin. Here, we have described a board 565 
host-range tailocin with activity against both human and plant pathogenic members of the genus 566 
Burkholderia. Recent studies with modified R-type tailocins have shown therapeutic promise in 567 
a murine model of P. aeruginosa peritonitis (7) and in Clostridium difficile infection (61). 568 
Evaluations of BceTMilo in both an animal and plant models are needed to determine its 569 
potential as a potential treatment for Burkholderia.   570 
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Figure legends 749 
FIG 1 Transmission electron micrographs of IEF purified tailocin BceTMilo. Samples were 750 
negatively stained with 2% (wt/vol) aqueous uranyl acetate. Bar indicated 100 nm. (A) X 25 K, 751 
contracted tailocin were shown. (B) X 100 K, arrows indicated tail fibers. 752 
 753 
FIG 2 SDS-PAGE of the IEF-purified tailocin BceTMilo. Protein subunits of tailocin BceTMilo 754 
were dissociated as described in Materials and Methods and loaded on (A) 10-20% Tris-HCl 755 
SDS gel or (B) 7.5% Tris-HCl SDS gel. Lane 1, molecular mass standards (Precision Plus 756 
protein standard from Bio-Rad; 10–250 kDa); Lane 2, subunits of tailocin BceTMilo. Proteins 757 
were visualized using Coomassie blue staining. Please note that the white lines between lanes 1 758 
and 2 for both Figure 2A and 2B indicate that a lane was removed from each of the original gels, 759 
since data was not presented in Results. 760 
 761 
FIG 3 Genomic map of BceTMilo and syntenic comparison. (A) Syntenic relationship of tailocin 762 
BceTMilo compared to tailocin locus on B. cenocepacia J2315. (B) Syntenic comparison of 763 
tailocin BceTMilo, Burkholderia phage KL3 and Enterobacteria phage P2. The genomic maps 764 
were drawn to scale. Genes were color coded according to Dice amino acid similarity compared 765 
to Burkholderia phage KL3 and the related genes were connected with dotted lines. 766 
 767 
FIG 4 Effect of Burkholderia LPS on BceTMilo. Increasing amounts of purified LPS from (A) B. 768 
cenocepacia strain PC184 (sensitive) and (B) B. cenocepacia strain AU10487 (resistant) were 769 
mixed with tailocin BceTMilo and allowed to incubate for 30 min. A 1:2 dilution series (See 770 
 o
n
 Septem
ber 11, 2018 by guest
http://aem
.asm
.org/
D
ow
nloaded from
 
37 
 
Materials and Methods) of mixtures from (A) and (B) were spotted to overlays seeded with strain 771 
PC184 to determine residual BceTMilo activity. Results are representative of triplicate 772 
experiments.   773 
 774 
FIG 5 Sugar inhibition assay.  Effects of D-galactose, α-D-glucose, D-fructose, D-775 
Mannoheptose, L-rhamnose, D-cellobiose, lactose, sucrose, and D-raffinose on tailocin 776 
adsorption to B. cenocepacia strain PC184.  The titer was expressed as the reciprocal of the 777 
highest dilution showing inhibition. 778 
*Indicates sugars that inhibited tailocin BceTMilo adsorption.  Results are representative of 779 
triplicate experiments. Each bar represents the standard deviation.  780 
 781 
FIG 6 Sensitivity of P. aeruginosa LPS mutants to tailocin BceTMilo. (A) Activity of serially 782 
diluted (1:10) tailocin BceTMilo against: PAO1 (i); PAO1wbpM (ii); PAO1wbpL (iii); 783 
PAO1rmlC (iv); or PAO1algC (v). (B) Circled numbers indicated in Fig. 5(A) correspond to 784 
depicted LPS structure with same number indicated in Fig. 5(B). Putative residues involved in 785 
BceTMilo adsorption are circled. Abbreviations: Man, mannose; Fuc, fucose; GalN, N-786 
galactosamine; HEP, Mannoheptose; NAG, N-acetylglucosamine; KDO, 2-keto-3 787 
deoxyoctulosonic acid. Figure adapted from Kohler et al. (2010) 788 
 789 
FIG 7 Electrophoretic profiles of LPS from B. cenocepacia K56-2, J2315, K56-2 and K56-2 790 
deletion mutants and complements. LPS prepared as described in Materials and Methods. A total 791 
of 1.0 µg LPS was loaded in each lane of a 16.5% polyacrylamide gel in a Tricine-SDS system 792 
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and developed by silver staining as described in Materials and Methods. Please note that the 793 
white line between lanes 3 and 4 indicates that a lane was removed from the original gel, since 794 
data was not presented for the strain in Results. 795 
 796 
FIG 8 Sensitivity of B. cenocepacia strain K56-2, J2315, and K56-2 LPS mutants to tailocin 797 
BceTMilo. (A) Activity of serially diluted (1:10) tailocin BceTMilo against: K56-2 (i);  J2315 798 
(ii); K56-2 ∆waaL (iii); or K56-2 ∆waaC (iv); K56-2 ∆waaL complement (v); or K56-2 ∆waaC 799 
complement (vi). (B) Circled numbers indicated in Fig. 8A correspond to depicted LPS structure 800 
with same numbers indicated in Fig. 8B.  Residues involved in BceTMilo adsorption are circled. 801 
Abbreviations: OS, oligosaccharide; HEP, L-glycero-D-manno-heptose; KO, D-glycero-α-D-802 
talo-oct-2-ulopyranolsylonic acid; KDO, 2-keto-3 deoxyoctulosonic acid; QuiNAc, β-D-QuiNAc. 803 
Above structure modified from Ortega et al. (2009) 804 
  805 
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TABLE 1 Bacterial strains and plasmids used in this study 806 
Strain  Relevant Characteristics Reference or Source 
Burkholderia 
cenocepacia 
  
BC0425 Producer of BceTMilo, ET12 
epidemic lineage, clinical isolate 
Laboratory collection 
AU10487 Clinical isolate Laboratory collection 
K56-2 ET12 epidemic lineage, O-antigen+ Sokol et al.(1999) 
J2315 ET12 epidemic lineage, O-antigen- Laboratory collection 
PC184 Midwest epidemic lineage, O-antigen- Laboratory collection 
BC0425 Δ recA BC0425, deleted recA gene This study 
K56-2 Δ waaL K56-2, deleted waaL gene, O-antigen- 
L-Rham-  
This study 
K56-2Δ waaC K56-2, deleted waaC gene, O-antigen- 
L-Rham- Glu- 
This study 
Escherichia coli   
E. cloni ® 5-alpha fhuA2Δ(argF-lacZ)U169 phoA 
glnV44 Φ80 Δ(lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17 
Lucigen 
Pseudomonas aeruginosa   
PAO1 LPS A+ LPS B+, R2 pyocin producer J. S. Lam (Burrows et al., 
1996) 
PAO1wbpM LPS A+ LPS B- J. S. Lam (Burrows et al., 
1996)  
PAO1wbpL LPS A- LPS B- J. S. Lam (Rocchetta et 
al., 1998b)  
PAO1rmlC LPS A- LPS B- L-Rham- J. S. Lam (Rocchetta et 
al., 1998a)  
PAO1algC LPS A- LPS B- L-Rham-  Glu- J. S. Lam (Jarrell et al., 
1977)  
NIH-K R1 pyocin producer ATCC25350 
NIH-1 R5 pyocin producer ATCC25313 
Plasmids    
pRK2013 Tra+ Mob+ ColE1 replicon Kmr Laboratory Stock  
pMo130 Suicide vector for allelic exchange in 
Burkholderia; ColE1 ori RK2 oriT 
xylE sacB Kmr 
M. I. Voskuil (Hamad et 
al., 2009) 
pMo168 Replicative vector for Burkholderia; 
oripBBR1 mob+,xylE KmR 
M. I. Voskuil (Hamad et 
al., 2009) 
pMo130:: recA-UD pM0130 with recA upstream and 
downstream fragments 
This study 
pMo130:: waaL-UD pM0130 with waaL upstream and 
downstream fragments 
This study 
pmo130:: waaC-UD pM0130 with waaC upstream and This study 
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downstream fragments 
pMo168:: recA-comp recA gene cloned into pMo168 This study 
pMo168:: waaL-comp waaL gene cloned into pMo168 This study 
pMo168:: waaC-comp waaC gene cloned into pMo168 This study 
Kmr: resistance to kanamycin.   
 807 
  808 
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TABLE 2 Primers used in this study 809 
Primer Relevant Characteristics 
recA-up-F 5'-GTGGCTAGCTGACCGGATGGATCTGGCGCG-3' 
recA-up-R 5'-CTCAGATCTCAGCGTCTGTTGGAGGCGCGC-3' 
recA-down-F 5'-GTGAGATCTGAGTGATGGTTGCGCGCCGAG-3' 
recA-down-R 5'-GTGAAGCTTACGGGCTCGGATAGCGGCATG-3' 
waaL-up-F 5'-GTGCGGCCGCTCGCTTCGCCGAGCACCATG-3' 
waaL-up-R 5'-GTGGGATCCTCTGGGCATTTGCCGGGCTGG-3' 
waaL-down-F 5'-GTCGGATCCAAGACGCTCCATACGCGCCG-3' 
waaL-down-R 5'-GACTTCTAGAGCGCACCATCTCCTGCTCGG-3' 
waaC-up-F 5'-CTGGCTAGCCCCGGGTATTGCGTCGAA-3' 
waaC-up-R 5'-GTCAGATCTCCTACTGGTCGCCGAACGTCGT-3' 
waaC-down-F 5'-GTCAGATCTCAGCCGGCGACAGACATAAAG-3' 
waaC-down-R 5'-CGTAAGCTTCAATCGACGTCGCGGATCAGT-3' 
recA-comp-F 5'-CTCGGATCCGGAAGATAGCAAGAAGGGCTC-3' 
recA-comp-R 5'-CTCTCTAGACTCGGCGCGCAACCATCACTC -3' 
waaL-comp-F 5'-GTGGATCCCATGAGCGGGCTGTCGGTGG-3' 
waaL-comp-R 5'-CACTTCTAGACAGCAATCGCACGGGCTTGC-3' 
waaC-comp-F 5'-CACCTGCAGTCGGTTCGCGTGTGGACAGC-3' 
waaC-comp-R 5'-GACGGATCCTATGTCTGTCGCCGGCTGCC-3' 
Added restriction site is underlined. 810 
 811 
TABLE 3 Tailocin BceTMilo efficiency of killing   812 
Tail major 
proteins 
Protein Mass 
(ng/10μl) 
Protein Moleculesa 
1014 per ml 
Tailocin Particlesb 
1011 per ml 
KUc  
1011 per ml  EOK
d 
Sheath        
(43 kDa) 
91 1.3 6.27 3.89 0.6 
144 2.0 9.89 3.89 0.4 
151 2.1 10.40 12.30 1.2 
473 6.6 32.40 12.30 0.4 
Tube         
(17 kDa) 
36 1.3 6.20 3.89 0.6 
94 3.3 16.30 3.89 0.2 
322 11.0 55.80 12.30 0.2 
Avg   0.5 
a Protein Molecules = ((Protein Mass X 1E-9) X 100/ Molecular Mass) X Avogadro's Number 813 
b Tailocin Particles = Protein molecules/204e 814 
c KU = Killing Unit 815 
d EOK = KU/Tailocin Particle 816 
e = Protein Molecules (tube or sheath)/Tailocin 817 
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 818 
TABLE 4 Burst size of tailocin BceTMiloa  819 
  
Total Cell No. 
(109) 
Total KUb 
(1012) KU/Cell 
Exp 1 7.1 4.73 660 
Exp 2 3.5 2.14 610 
Exp 3 6.0 3.49 580 
Avg     620 
a Burst size was calculated as total KU of lysates divided by total  820 
Cell No. exposed to UV.  821 
b KU = Killing Unit 822 
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